![Andrey Mladentsev](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Healthcare professional.
Former VP CIS & Baltics at Stada, CEO at Promomed, CEO at NizhPharm (acquired by Stada), CEO at OBL Pharm (acquired by AFK Sistema).
Eerdere bekende functies van Andrey Mladentsev
| Bedrijven | Functie | Einde |
|---|---|---|
| STADA ARZNEIMITTEL | Private Equity Investor | 01-03-2007 |
V12 Venture Israel MC Ltd.
 V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel invests in companies located in Israel. The firm focuses on companies operating in the fields of deep technology services. It provides financing for seed and early stage capital requirements. | Consultant / Adviseur | - |
Opleiding van Andrey Mladentsev
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: GenericHealth Technology Manufactures generic drugs and pharmaceuticals | Health Technology |
IEDC Bled School of Management
 IEDC Bled School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
V12 Venture Israel MC Ltd.
V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel invests in companies located in Israel. The firm focuses on companies operating in the fields of deep technology services. It provides financing for seed and early stage capital requirements. | Finance |
